Research & Development



  “你剛才不是已經想出法子來了嗎?”   蒙查這個蠢貨,根本就不知道,匈奴人在大月氏大肆的燒殺劫掠,卻不知這里到處都是被雲瑯雇佣的大月氏商人。亚洲人妻av伦理   到時候漢國的精髓沒有學到,我們反而丟了匈奴人的生活方式。”经典AV三级在线   男人的好時光就那麼短短的幾年,隨著時光流逝,不好的隱性的東西就會全部冒出來,最終把一個個好好地美少年變成豬。   “弟子在敦煌的事情已經做完,是否可以提前回姑臧城?”欧美色情在线-777米奇色狠狠俺去啦-俺也来俺也去俺也射成人网   這些蘆葦蕩產生的原因是下雨,蘆葦蕩里並沒有活水注入,雲瑯百思不得其解,這里的魚都是從哪里來的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo